U of Masaryk Nezvedova lab - Nezvedova et al. Serum-derived HSA as a source of undeclared proteins in IVF media

Serum-derived human serum albumin as a source of undeclared proteins and compositional variability in commercially available IVF media
Data License: CC BY 4.0 | ProteomeXchange: PXD063038 | doi: https://doi.org/10.6069/vkze-gj62
  • Organism: Homo sapiens
  • Instrument: 6495B Triple Quadrupole LC/MS
  • SpikeIn: Yes
  • Keywords: IVF media composition, human serum albumin, spent culture medium, embryo culture, proteomics
  • Lab head: Marketa Nezvedova Submitter: Marketa Nezvedova
Abstract
Advanced mass spectrometry analysis showed that not only SCM but also unconditioned IVF medium contains a large number of undeclared proteins known to play roles in cellular regulatory pathways. To eliminate the impact of protein background in embryo-free media, SCM samples were normalized to corresponding controls. We observed no significant difference in the proteome fingerprint of individual embryos that developed to blastocyst and their cleavage stage-arrested siblings. Instead, we observed lot-to-lot variability in specific protein abundance. To test whether the protein composition variation can be attributed to the addition of a plasma-derived protein, we supplemented a protein-free medium with HSA of different origins. This experiment revealed that adding HSA purified from plasma introduces batch-related divergence in undeclared protein content, contributing to variability in the media's protein composition. In contrast, the analyzed contaminating proteins of human origin were undetectable after the addition of recombinant HSA, highlighting its potential as a alternative for embryo culture. The findings of this study indicate that the protein background in commercial IVF media is an overlooked variable in human embryo cultures, which compromises the reproducibility and interpretation of embryonic secretome analyses.
Experiment Description
A cross-sectional proteomic study involving a total of 85 samples of (un)used monophasic IVF culture media purchased from 2 manufacturers as 13 different production lots. The protein composition of 53 SCM samples from 22 IVF cycles collected between February 2022 and June 2023 was analyzed together with corresponding controls and available blank media samples.
Sample Description
Untargeted (nanoLC-TIMS-TOF-MS/MS) and targeted (UHPLC-QqQ-MS/MS) proteomic analyses were used to identify the protein content of media from extended embryo cultures with known embryo quality. The SCM sampling from individual embryo culture droplets was performed along with their controls. Each new batch of culture media was sampled before use (blank samples). In addition, the protein composition of HSA-free IVF media supplemented with either serum-derived HSA or recombinant HSA (rec-HSA) was examined.
Created on 4/16/25, 12:07 PM
Clustergrammer Heatmap
 
Download
IVF_protein-free_media_with_albumin_addition_targeted_MS_analysis_2025-04-16_14-50-46.sky.zip2025-04-16 12:06:5915356222020
IVF_blank_media_batches_targeted_MS_analysis_2025-04-16_14-49-08.sky.zip2025-04-16 12:06:5915356222036
Individual_SCM_and_CTR_samples_targeted_MS_analysis_2025-04-16_14-44-59.sky.zip2025-04-16 12:06:5915356222045